These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1886291)

  • 1. Hyperuricemia induced by the uricosuric drug probenecid in rats.
    Shinosaki T; Yonetani Y
    Jpn J Pharmacol; 1991 Apr; 55(4):461-8. PubMed ID: 1886291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of uricosuric drugs and diuretics on uric acid excretion in oxonate-treated rats.
    Yonetani Y; Iwaki K
    Jpn J Pharmacol; 1983 Oct; 33(5):947-54. PubMed ID: 6645117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia induced by some antihypertensives and uricosuric drugs in oxonate-treated rats.
    Yonetani Y; Ishii M; Iwaki K
    Jpn J Pharmacol; 1980 Dec; 30(6):829-40. PubMed ID: 7241859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoproterenol on renal uric acid excretion in rats.
    Sugino H; Shimada H
    Jpn J Pharmacol; 1987 Nov; 45(3):343-8. PubMed ID: 3437600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine-induced hyperuricemia in eviscerated rats with functional hepatectomy.
    Yonetani Y; Iwaki K
    Jpn J Pharmacol; 1981 Jun; 31(3):323-32. PubMed ID: 6895530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probenecid on oxypurines in plasma.
    Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor.
    Taniguchi T; Ashizawa N; Matsumoto K; Iwanaga T; Saitoh K
    J Pharm Pharmacol; 2016 Jan; 68(1):76-83. PubMed ID: 26589240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
    Hiroshige K; Takasugi M; Yuu K; Kuroiwa A
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased renal excretion of uric acid following diuretic administration in rats.
    Iwaki K; Yonetani Y
    Jpn J Pharmacol; 1984 Apr; 34(4):389-96. PubMed ID: 6374219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The excretion of 14C-hypoxanthine and its metabolites in rats following administration of uricostatic drugs.
    von Kerékjártó B; Hropot M
    Adv Exp Med Biol; 1984; 165 Pt A():179-83. PubMed ID: 6720376
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal pathogenesis of familial hyperuricemia: studies in two kindreds.
    Stapleton FB; Nyhan WL; Borden M; Kaufman IA
    Pediatr Res; 1981 Nov; 15(11):1447-53. PubMed ID: 7301465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing effect of allantoxanamide, a hyperuricemic agent on renal functions in rats.
    Yonetani Y; Iwaki K; Ogawa Y
    Jpn J Pharmacol; 1987 Sep; 45(1):37-43. PubMed ID: 3119902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of xanthinuria: a study on the metabolism of pyrazinamide and allopurinol.
    Yamamoto T; Kario K; Suda M; Moriwaki Y; Takahashi S; Higashino K
    Jpn J Med; 1991; 30(5):430-4. PubMed ID: 1803043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid.
    Rodilla F; Sanchez-Beltran MJ; Izquierdo R; Gomez-Ruiz MD; Cabo J
    Biochem Pharmacol; 1988 Oct; 37(19):3561-3. PubMed ID: 3178870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolites in congenital hyperuricosuria.
    Balis ME; Krakoff IH; Berman PH; Dancis J
    Science; 1967 May; 156(3778):1122-3. PubMed ID: 6024192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure.
    Andreoli SP; Clark JH; McGuire WA; Bergstein JM
    J Pediatr; 1986 Aug; 109(2):292-8. PubMed ID: 3461147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of oxonate-induced hyperuricemia and allopurinol on behavioral reactions of random-bred mice.
    Tovchiga O; Shtrygol S
    J Basic Clin Physiol Pharmacol; 2012; 23(4):147-51. PubMed ID: 23023694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.